The US drug regulator has approved the Armlupeg (pegfilgrastim-unne) 6mg / 0.6 ml injection for subcutaneous use in a ...
Mumbai, Aug. 26 -- The company also received tentative approval for the (0.2 Units/mL) RTU vials of the same formulation. The product is bioequivalent and therapeutically equivalent to the reference ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback